Search research articles
Contact Us
Filters
Showing results (441-450 of 472) with videos related to
Page
of 48
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 2021
Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322]
M A Dimopoulos, P Moreau, E Terpos, et al.
Genome Research
|
December 28, 2020
Modeling molecular development of breast cancer in canine mammary tumors
Kiley Graim, Dmitriy Gorenshteyn, David G Robinson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P Moreau, J San Miguel, P Sonneveld, et al.
Leukemia
|
June 23, 2012
A gene expression signature for high-risk multiple myeloma
R Kuiper, A Broyl, Y de Knegt, et al.
Veterinary Pathology
|
November 15, 2013
Canine mammary tumors: a review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry
L Peña, A Gama, M H Goldschmidt, et al.
Journal of Virology
|
June 16, 2006
Severe papillomavirus infection progressing to metastatic squamous cell carcinoma in bone marrow-transplanted X-linked SCID dogs
Michael H Goldschmidt, Jeffrey S Kennedy, Douglas R Kennedy, et al.
Leukemia
|
November 29, 2016
The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment
F Fan, M H Bashari, E Morelli, et al.
Bone Marrow Transplantation
|
April 21, 2001
Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)
B Björkstrand, H Svensson, H Goldschmidt, et al.
Oncogene
|
September 1, 2009
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis
A Seckinger, T Meissner, J Moreaux, et al.
Leukemia
|
October 4, 2012
Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project
H Avet-Loiseau, B G M Durie, M Cavo, et al.
Page
of 48
Search research articles
Search
Showing results (441-450 of 472) with videos related to
Sort By:
Page
of 48
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 2021
Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322]
M A Dimopoulos, P Moreau, E Terpos, et al.
Genome Research
|
December 28, 2020
Modeling molecular development of breast cancer in canine mammary tumors
Kiley Graim, Dmitriy Gorenshteyn, David G Robinson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P Moreau, J San Miguel, P Sonneveld, et al.
Leukemia
|
June 23, 2012
A gene expression signature for high-risk multiple myeloma
R Kuiper, A Broyl, Y de Knegt, et al.
Veterinary Pathology
|
November 15, 2013
Canine mammary tumors: a review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry
L Peña, A Gama, M H Goldschmidt, et al.
Journal of Virology
|
June 16, 2006
Severe papillomavirus infection progressing to metastatic squamous cell carcinoma in bone marrow-transplanted X-linked SCID dogs
Michael H Goldschmidt, Jeffrey S Kennedy, Douglas R Kennedy, et al.
Leukemia
|
November 29, 2016
The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment
F Fan, M H Bashari, E Morelli, et al.
Bone Marrow Transplantation
|
April 21, 2001
Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)
B Björkstrand, H Svensson, H Goldschmidt, et al.
Oncogene
|
September 1, 2009
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis
A Seckinger, T Meissner, J Moreaux, et al.
Leukemia
|
October 4, 2012
Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project
H Avet-Loiseau, B G M Durie, M Cavo, et al.
Page
of 48